- FDA approval received for prefilled syringe format of Purified Cortrophin Gel.
 - The drug is indicated for acute exacerbations of various conditions including rheumatoid arthritis and psoriatic arthritis.
 - Caution is advised for patients with comorbid conditions and during pregnancy.
 - Contraindications include systemic fungal infections, ocular herpes simplex, congestive heart failure, recent surgery, and primary adrenocortical insufficiency.
 - Potential adverse effects may include fluid retention, muscle weakness, osteoporosis, hypertension, mood alterations, and immunosuppression.
 
                Conexiant
                
                    chevron_right
                    Rheumatology
                
                chevron_right
                FDA Approves Prefilled Syringe for Cortrophin Gel
            
  
        Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Advertisement
                                Recommendations
Advertisement